Page 67 - 2023 SMOG Digital
P. 67

Environmental


                      Global Spider and Scorpion Envenomation (Continued)

         Scorpions:
              Scorpions envenomate humans by stinging them with the telson on their tail. Around 20 species
              of medically important (meaning potentially lethal to humans) scorpions are known, and all but
              one of these (Hemiscorpius lepturus) are members of the Buthidae family. Buthidae family
              contains the large genera Ananteris, Centruroides, Compsobuthus, and Tityus. Centruroides are
              the only clinically significant venomous scorpion indigenous to the United States (i.e., Bark
              Scorpions).  The majority of medically significant envenomations occur in the Middle East,
              tropics (e.g., Southwest Asia, India, Central and South America), and North Africa.
              Scorpion venoms are complex and can include phospholipase, acetylcholinesterase,
              hyaluronidase, serotonin, and neurotoxins. Scorpion venom increases neuronal release by
              blocking inactivation of the sodium channel, resulting in an increase in the amplitude and
              duration of neuron action potential. The overall result is excess stimulation of the central
              nervous system, the neuromuscular system, the sympathetic nervous system, and the
              parasympathetic nervous system.
              The components of scorpion venom are species specific and generally fall into the categories of
              neurotoxic and cardiotoxic; however, this terminology is misleading since the cardiotoxic effects
              are secondary to an excess release of catecholamines stimulated by the nervous system. The
              venom of the unique species, Hemicorpius lepturus, found in Iraq and Iran is predominately
              cytotoxic, similar to the brown recluse spider.
              Antivenom is available for some species; data regarding the benefits and risks of many of these
              antivenoms are significantly limited. In patients with moderate to severe symptoms refractory
              to analgesics and benzodiazepines, antivenom, if available, may be indicated. Due to the high
              risk of immediate or delayed allergic reactions to these antivenoms administration should be
              done at a controlled clinical location and pre-hospital treatment should be focused on
              supportive care. Intravenous histamine antagonists (i.e. diphenhydramine), steroids, and
              epinephrine should be immediately available at the patient’s bedside prior to antivenom   ENVIRONMENTAL
              administration. The Joint Trauma System Clinical Practice Guideline: Global Spider and Scorpion
              Envenomation Management (CPG ID: 84) contains a list of antivenoms available by country.
              (https://jts.amedd.army.mil/assets/docs/cpgs/Global_Spider_and_Scorpion_Envenomation_Ma
              nagement_09_Feb_2021_ID84.pdf)


         Prehospital/En Route Care Treatment Goals for Spider and Scorpion Bites and Stings:
              Some moderate to severe cases of envonomations will require medical evacuation to a
              treatment facility with the capability to administer antivenom. En Route Care consists primarily
              of supportive care and pain management. En route care providers should be prepared to
              counter cholernergic, adrenergic, sympathetic and parasympathetic effects.  Aggressive use of
              benzodiazepines as indicated for agitation, neuromuscular stimulation, tachycardia, and
              hypertension. Secure the airway and initiate mechanical ventilation if indicated.  Anaphylaxis is
              the most concerning initial effect.  See specific treatment guidelines for Widow Spiders,
              Funnel-Web Spiders and Scorpions for additional guidance.




                                                                        67
   62   63   64   65   66   67   68   69   70   71   72